Polycystic Ovarian Syndrome

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      PDF Download and 24 Hours Online Access
      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Medical Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. Consensus on women's health aspects of polycystic ovary syndrome (PCOS).
        Hum Reprod. 2012; 27: 14-24https://doi.org/10.1093/humrep/der1396
        • Wood J.R.
        • Dumesic D.A.
        • Abbott D.H.
        • et al.
        Molecular abnormalities in oocytes from women with polycystic ovary syndrome revealed by microarray analysis.
        J Clin Endocrinol Metab. 2007; 92: 705-713
        • Ferriman D.
        • Gallwey J.D.
        Clinical assessment of body hair growth in women.
        J Clin Endocrinol Metab. 1961; 21: 1440-1447
        • Conway G.S.
        • Dewailly D.
        • Diamanti-Kandarakis E.
        • et al.
        The polycystic ovary syndrome: an endocrinological perspective from the European Society of Endocrinology.
        Eur J Endocrinol. 2014; 171: 489-498
        • Dunaif A.
        • Segal K.R.
        • Futterweit W.
        • et al.
        Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome.
        Diabetes. 1989; 38: 1165-1174
        • DeUgarte C.M.
        • Bartolucci A.A.
        • Azziz R.
        Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment.
        Fertil Steril. 2005; 83: 1454-1460
        • Tamega Ade A.
        • Aranha A.M.
        • Guiotoku M.M.
        • et al.
        Association between skin tags and insulin resistance.
        An Bras Dermatol. 2010; 85 ([in Portuguese]): 25-31
        • Plascencia Gomez A.
        • Vega Memije M.E.
        • Torres Tamayo M.
        • et al.
        Skin disorders in overweight and obese patients and their relationship with insulin.
        Actas Dermosifiliogr. 2014; 105: 178-185https://doi.org/10.1016/j.ad.2013.09.1008
        • Apridonidze T.
        • Essah P.A.
        • Iuorno M.J.
        • et al.
        Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome.
        J Clin Endocrinol Metab. 2005; 90: 1929-1935
        • Dokras A.
        • Bochner M.
        • Hollinrake E.
        • et al.
        Screening women with polycystic ovary syndrome for metabolic syndrome.
        Obstet Gynecol. 2005; 106: 131-137
        • Legro R.S.
        • Kunselman A.R.
        • Dodson W.C.
        • et al.
        Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women.
        J Clin Endocrinol Metab. 1999; 84: 165-169
        • Ehrmann D.A.
        • Barnes R.B.
        • Rosenfield R.L.
        • et al.
        Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.
        Diabetes Care. 1999; 22: 141-146
        • Ehrmann D.A.
        • Kasza K.
        • Azziz R.
        • et al.
        Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome.
        J Clin Endocrinol Metab. 2005; 90: 66-71
        • Kelly C.J.
        • Speirs A.
        • Gould G.W.
        • et al.
        Altered vascular function in young women with polycystic ovary syndrome.
        J Clin Endocrinol Metab. 2002; 87: 742-746
        • Talbott E.
        • Guzick D.
        • Clerici A.
        • et al.
        Coronary heart disease risk factors in women with polycystic ovary syndrome.
        Arterioscler Thromb Vasc Biol. 1995; 15: 821-826
        • Vgontzas A.N.
        • Legro R.S.
        • Bixler E.O.
        • et al.
        Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance.
        J Clin Endocrinol Metab. 2001; 86: 517-520
        • Tasali E.
        • Van Cauter E.
        • Ehrmann D.A.
        Relationships between sleep disordered breathing and glucose metabolism in polycystic ovary syndrome.
        J Clin Endocrinol Metab. 2006; 91: 36-42
        • Schwimmer J.B.
        • Khorram O.
        • Chiu V.
        • et al.
        Abnormal aminotransferase activity in women with polycystic ovary syndrome.
        Fertil Steril. 2005; 83: 494-497
        • Barry J.A.
        • Kuczmierczyk A.R.
        • Hardiman P.J.
        Anxiety and depression in polycystic ovary syndrome: a systematic review and meta-analysis.
        Hum Reprod. 2011; 26: 2442-2451https://doi.org/10.1093/humrep/der197
        • McCartney C.R.
        • Eagleson C.A.
        • Marshall J.C.
        Regulation of gonadotropin secretion: implications for polycystic ovary syndrome.
        Semin Reprod Med. 2002; 20: 317-326
        • Ehrmann D.A.
        Polycystic ovary syndrome.
        N Engl J Med. 2005; 352: 1223-1236
        • Tsilchorozidou T.
        • Overton C.
        • Conway G.S.
        The pathophysiology of polycystic ovary syndrome.
        Clin Endocrinol (Oxf). 2004; 60: 1-17
        • Diamanti-Kandarakis E.
        • Dunaif A.
        Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.
        Endocr Rev. 2012; 33: 981-1030https://doi.org/10.1210/er.2011-1034
        • Sam S.
        • Legro R.S.
        • Essah P.A.
        • et al.
        Evidence for metabolic and reproductive phenotypes in mothers of women with polycystic ovary syndrome.
        Proc Natl Acad Sci U S A. 2006; 103: 7030-7035
        • Legro R.S.
        • Kunselman A.R.
        • Demers L.
        • et al.
        Elevated dehydroepiandrosterone sulfate levels as the reproductive phenotype in the brothers of women with polycystic ovary syndrome.
        J Clin Endocrinol Metab. 2002; 87: 2134-2138
        • Sam S.
        • Sung Y.A.
        • Legro R.S.
        • et al.
        Evidence for pancreatic beta-cell dysfunction in brothers of women with polycystic ovary syndrome.
        Metabolism. 2008; 57: 84-89
        • Fauser B.C.
        • Tarlatzis B.C.
        • Rebar R.W.
        • et al.
        Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group.
        Fertil Steril. 2012; 97: 28-38.e25https://doi.org/10.1016/j.fertnstert.2011.1009.1024
        • Keevil B.G.
        How do we measure hyperandrogenemia in patients with PCOS?.
        J Clin Endocrinol Metab. 2014; 99: 777-779https://doi.org/10.1210/jc.2014-1307
        • O'Reilly M.W.
        • Taylor A.E.
        • Crabtree N.J.
        • et al.
        Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione.
        J Clin Endocrinol Metab. 2014; 99: 1027-1036https://doi.org/10.1210/jc.2013-3399
        • Eilertsen T.B.
        • Vanky E.
        • Carlsen S.M.
        Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced?.
        Hum Reprod. 2012; 27: 2494-2502https://doi.org/10.1093/humrep/des213
        • Legro R.S.
        • Arslanian S.A.
        • Ehrmann D.A.
        • et al.
        Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline.
        J Clin Endocrinol Metab. 2013; 98: 4565-4592https://doi.org/10.1210/jc.2013-2350
        • Johnstone E.B.
        • Rosen M.P.
        • Neril R.
        • et al.
        The polycystic ovary post-Rotterdam: a common, age-dependent finding in ovulatory women without metabolic significance.
        J Clin Endocrinol Metab. 2010; 95: 4965-4972https://doi.org/10.1210/jc.2010-0202
        • Dewailly D.
        • Lujan M.E.
        • Carmina E.
        • et al.
        Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society.
        Hum Reprod Update. 2014; 20: 334-352https://doi.org/10.1093/humupd/dmt061
        • Martin K.A.
        • Chang R.J.
        • Ehrmann D.A.
        • et al.
        Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline.
        J Clin Endocrinol Metab. 2008; 93: 1105-1120https://doi.org/10.1210/jc.2007-2437
        • Usadi R.S.
        • Legro R.S.
        Reproductive impact of polycystic ovary syndrome.
        Curr Opin Endocrinol Diabetes Obes. 2012; 19: 505-511https://doi.org/10.1097/MED.0b013e328359ff92
        • Legro R.S.
        • Barnhart H.X.
        • Schlaff W.D.
        • et al.
        Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome.
        N Engl J Med. 2007; 356: 551-566
        • Morin-Papunen L.
        • Rantala A.S.
        • Unkila-Kallio L.
        • et al.
        Metformin improves pregnancy and live-birth rates in women with polycystic ovary syndrome (PCOS): a multicenter, double-blind, placebo-controlled randomized trial.
        J Clin Endocrinol Metab. 2012; 97: 1492-1500https://doi.org/10.1210/jc.2011-3061
        • Palomba S.
        • Falbo A.
        • Carrillo L.
        • et al.
        Metformin reduces risk of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during gonadotropin-stimulated in vitro fertilization cycles: a randomized, controlled trial.
        Fertil Steril. 2011; 96: 1384-1390.e4
        • Legro R.S.
        • Brzyski R.G.
        • Diamond M.P.
        • et al.
        The pregnancy in polycystic ovary syndrome II study: baseline characteristics and effects of obesity from a multicenter randomized clinical trial.
        Fertil Steril. 2014; 101: 258-269.e8https://doi.org/10.1016/j.fertnstert.2013.08.056
        • Perales-Puchalt A.
        • Legro R.S.
        Ovulation induction in women with polycystic ovary syndrome.
        Steroids. 2013; 78: 767-772https://doi.org/10.1016/j.steroids.2013.05.005
        • Knowler W.C.
        • Barrett-Connor E.
        • Fowler S.E.
        • et al.
        Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.
        N Engl J Med. 2002; 346: 393-403
        • Bates G.W.
        • Legro R.S.
        Longterm management of polycystic ovarian syndrome (PCOS).
        Mol Cell Endocrinol. 2013; 373: 91-97https://doi.org/10.1016/j.mce.2012.1010.1029
        • Escobar-Morreale H.F.
        • Botella-Carretero J.I.
        • Alvarez-Blasco F.
        • et al.
        The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery.
        J Clin Endocrinol Metab. 2005; 90: 6364-6369
        • Eid G.M.
        • Cottam D.R.
        • Velcu L.M.
        • et al.
        Effective treatment of polycystic ovarian syndrome with Roux-en-Y gastric bypass.
        Surg Obes Relat Dis. 2005; 1: 77-80
        • Harrison C.L.
        • Lombard C.B.
        • Moran L.J.
        • et al.
        Exercise therapy in polycystic ovary syndrome: a systematic review.
        Hum Reprod Update. 2011; 17: 171-183
        • Winters S.J.
        • Talbott E.
        • Guzick D.S.
        • et al.
        Serum testosterone levels decrease in middle age in women with the polycystic ovary syndrome.
        Fertil Steril. 2000; 73: 724-729
        • Welt C.K.
        • Carmina E.
        Clinical review: lifecycle of polycystic ovary syndrome (PCOS): from in utero to menopause.
        J Clin Endocrinol Metab. 2013; 98: 4629-4638